Stéphane Thibault

654 total citations
16 papers, 462 citations indexed

About

Stéphane Thibault is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Stéphane Thibault has authored 16 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Stéphane Thibault's work include Advanced Breast Cancer Therapies (4 papers), Neuroendocrine Tumor Research Advances (2 papers) and Carcinogens and Genotoxicity Assessment (2 papers). Stéphane Thibault is often cited by papers focused on Advanced Breast Cancer Therapies (4 papers), Neuroendocrine Tumor Research Advances (2 papers) and Carcinogens and Genotoxicity Assessment (2 papers). Stéphane Thibault collaborates with scholars based in United States, United Kingdom and Chile. Stéphane Thibault's co-authors include Aida Sacaan, Wenyue Hu, Martin B. Finkelstein, Tae Sung, Bart Jessen, Nasir Khan, Ping Wei, Donna M. Stone, Kang Li and Jennifer Yang and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Stéphane Thibault

16 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stéphane Thibault United States	10	248	168	160	116	55	16	462
Ye Hu China	11	80 0.3×	224 1.3×	75 0.5×	96 0.8×	45 0.8×	19	374
Jessica Boklan United States	12	118 0.5×	215 1.3×	55 0.3×	41 0.4×	59 1.1×	30	467
Sung Soo Kim South Korea	17	156 0.6×	228 1.4×	158 1.0×	105 0.9×	60 1.1×	40	604
Wenhui Zhao China	11	251 1.0×	154 0.9×	104 0.7×	154 1.3×	43 0.8×	20	446
Jiunn-Chang Lin Taiwan	11	152 0.6×	150 0.9×	84 0.5×	79 0.7×	124 2.3×	27	426
Roland Eid Lebanon	11	242 1.0×	192 1.1×	154 1.0×	81 0.7×	54 1.0×	30	479
Satoe Fujiwara Japan	14	227 0.9×	279 1.7×	72 0.5×	169 1.5×	63 1.1×	38	677
Gh Rasool Bhat India	7	111 0.4×	184 1.1×	56 0.3×	101 0.9×	51 0.9×	19	394
Bruce S. Fischer United States	11	290 1.2×	224 1.3×	103 0.6×	44 0.4×	76 1.4×	22	574

Countries citing papers authored by Stéphane Thibault

Since Specialization

Citations

This map shows the geographic impact of Stéphane Thibault's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane Thibault with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane Thibault more than expected).

Fields of papers citing papers by Stéphane Thibault

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphane Thibault. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane Thibault. The network helps show where Stéphane Thibault may publish in the future.

Co-authorship network of co-authors of Stéphane Thibault

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphane Thibault. A scholar is included among the top collaborators of Stéphane Thibault based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphane Thibault. Stéphane Thibault is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Guha, Mausumee, Stéphane Thibault, Son M. Pham, et al.. (2024). Nonclinical Profile of PF-06952229 (MDV6058), a Novel TGFβRI/Activin Like Kinase 5 Inhibitor Supports Clinical Evaluation in Cancer. Journal of Pharmacology and Experimental Therapeutics. 391(2). 335–345. 1 indexed citations

Hu, Wenyue, Daniel J. Lettiere, Susanna Tse, et al.. (2021). Liver Toxicity Observed With Lorlatinib When Combined With Strong CYP3A Inducers: Evaluation of Cynomolgus Monkey as a Nonclinical Model for Assessing the Mechanism of Combinational Toxicity. Toxicological Sciences. 182(2). 183–194. 5 indexed citations

Catlin, Natasha R., Christopher Bowman, Aida Sacaan, et al.. (2019). Reproductive and developmental toxicity assessment of palbociclib, a CDK4/6 inhibitor, in Sprague-Dawley rats and New Zealand White rabbits. Reproductive Toxicology. 88. 76–84. 16 indexed citations

Sacaan, Aida, Stéphane Thibault, & Kanwar Nasir M. Khan. (2019). Central nervous system tumors in 2-year rat carcinogenicity studies: perspectives on human risk assessment. The Journal of Toxicological Sciences. 44(10). 643–655. 1 indexed citations

Thibault, Stéphane, Wenyue Hu, Brad Hirakawa, et al.. (2018). Intestinal Toxicity in Rats Following Administration of CDK4/6 Inhibitors Is Independent of Primary Pharmacology. Molecular Cancer Therapeutics. 18(2). 257–266. 23 indexed citations

Peraza, Marjorie A., et al.. (2018). Nonclinical assessments of the potential biosimilar PF-06439535 and bevacizumab. Regulatory Toxicology and Pharmacology. 95. 236–243. 24 indexed citations

Sacaan, Aida, Stéphane Thibault, Tim Nichols, et al.. (2017). CDK4/6 Inhibition on Glucose and Pancreatic Beta Cell Homeostasis in Young and Aged Rats. Molecular Cancer Research. 15(11). 1531–1541. 17 indexed citations

Kahler, Jennifer, Maureen Dougher, Andreas Maderna, et al.. (2017). Abstract 3095: The development of CPI as a novel, next-generation DNA-targeting payload for ADCs. Cancer Research. 77(13_Supplement). 3095–3095. 1 indexed citations

Wang, Jian‐Ying, Wenhu Huang, Stéphane Thibault, et al.. (2016). Evaluation of miR-216a and miR-217 as Potential Biomarkers of Acute Exocrine Pancreatic Toxicity in Rats. Toxicologic Pathology. 45(2). 321–334. 17 indexed citations

10.

Hu, Wenyue, Tae Sung, Bart Jessen, et al.. (2015). Mechanistic Investigation of Bone Marrow Suppression Associated with Palbociclib and its Differentiation from Cytotoxic Chemotherapies. Clinical Cancer Research. 22(8). 2000–2008. 132 indexed citations

11.

Heyen, Jonathan R., Wenyue Hu, Joseph Jamieson, et al.. (2013). Cardiovascular differentiation of imatinib and bosutinib in the rat. International Journal of Hematology. 98(5). 597–607. 3 indexed citations

12.

Greaves, Peter, Luc Chouinard, Heinrich Ernst, et al.. (2013). Proliferative and Non-Proliferative Lesions of the Rat and Mouse Soft Tissue, Skeletal Muscle and Mesothelium. Journal of Toxicologic Pathology. 26(3_Suppl). 1S–26S. 43 indexed citations

13.

Roberts, Stanley, Paul A. Andrews, Diann Blanset, et al.. (2013). Considerations for the nonclinical safety evaluation of antibody drug conjugates for oncology. Regulatory Toxicology and Pharmacology. 67(3). 382–391. 25 indexed citations

14.

Qiu, Ming, Qinghai Peng, Christopher L. Carroll, et al.. (2012). Specific inhibition of Notch1 signaling enhances the antitumor efficacy of chemotherapy in triple negative breast cancer through reduction of cancer stem cells. Cancer Letters. 328(2). 261–270. 109 indexed citations

15.

Boobis, Alan R., Samuel M. Cohen, Nancy G. Doerrer, et al.. (2009). A Data-Based Assessment of Alternative Strategies for Identification of Potential Human Cancer Hazards. Toxicologic Pathology. 37(6). 714–732. 36 indexed citations

16.

Thibault, Stéphane, et al.. (1991). Cytologic features of premalignant glandular lesions in the upper gastrointestinal tract.. PubMed. 35(2). 199–203. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact